H35.13
Retinopathy of prematurity, stage 2
Clinical Classification Guidelines
Medical Intelligence & Overview
Retinopathy of Prematurity (ROP) is a potentially serious eye disorder that primarily affects premature infants. Stage 2 ROP indicates a moderate progression of abnormal blood vessel development in the retina. Understanding the condition, its causes, symptoms, diagnosis, and treatment options can help in managing and monitoring this condition effectively. This explanation aims to provide clear, patient-friendly information about retinopathy of prematurity, specifically at stage 2, coded as H35.13 in the ICD-10 system.
Causes & Symptoms
Clinical Causes: Premature birth, especially before 31 weeks of gestation Low birth weight, typically less than 3.3 pounds (1500 grams) Oxygen therapy received after birth, particularly if high doses are used Family history of eye problems or genetic predisposition Maternal health issues such as preeclampsia or placental problems
Key Symptoms: Abnormal eye movements Leukocoria, or a white reflection from the retina (sometimes visible as an unusual glow in photos) Poor vision or difficulty focusing in older infants Strabismus, or crossed eyes Partially or fully blocked vision in one or both eyes in advanced cases
Diagnostic & Treatment
Diagnosis Path: Diagnosing ROP involves a comprehensive eye examination by a pediatric ophthalmologist. The process includes: - Screening infants at risk based on gestational age and weight - Using specialized instruments like binocular indirect ophthalmoscopy to examine the retina - Assessing the blood vessel growth and any abnormal features - Staging the severity of ROP based on the International Classification of Retinopathy of Prematurity, which ranges from stage 1 (mild) to stage 5 (complete retinal detachment) The diagnosis of stage 2 ROP indicates that abnormal blood vessel growth has progressed beyond initial signs but is not yet advanced to more severe stages.
Treatment Protocols: The management of stage 2 ROP depends on the progression and severity of the condition. Possible interventions include: - Observation and regular monitoring to track the disease progression - Laser therapy to ablate the abnormal blood vessels and prevent further growth - Cryotherapy in some cases to destroy areas of the retina that are at risk - Anti-vascular endothelial growth factor (VEGF) injections, which inhibit abnormal blood vessel growth - Surgical procedures like vitrectomy for advanced cases where retinal detachment occurs Early detection and timely treatment are crucial in preventing vision loss and other complications related to ROP.
Clinical Advice & FAQs
Billing Guidance
Is H35.13 a billable ICD-10 code?
Yes, H35.13 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.13?
Clinical documentation must specify the nature of Retinopathy of prematurity, stage 2 and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
